Supplements and Mesalazine (Systemic).
Mesalazine (Systemic), sold under the brand names Asacol, Pentasa, Salofalk, Octasa, Mezavant XL, is an aminosalicylate: it acts topically on inflamed colonic mucosa in inflammatory bowel disease.
Mesalazine (Systemic) is an aminosalicylate (5-ASA), used in ulcerative colitis and some forms of Crohn disease. The class acts locally on inflamed colonic mucosa, with mesalazine as the dominant agent in current UK prescribing. Sulfasalazine remains in use for rheumatoid arthritis. Mechanism is local inhibition of prostaglandin and leukotriene synthesis at the colonic epithelium. The supplement surface is small because the drug acts locally with limited systemic absorption. Folate depletion can occur with sulfasalazine (the sulpha moiety competes with folate metabolism), and folate supplementation is sometimes given alongside. Iron deficiency is common in active inflammatory bowel disease and may need supplementation, with the standard separation rules for oral iron and oral 5-ASA. Probiotic use during active IBD is studied but the evidence base for specific strains remains modest. NSAIDs warrant care given the IBD relapse signal.
We have not yet completed an explicit assessment of supplement interactions with Mesalazine (Systemic) in the Distil database. That is different from saying nothing exists. We surface this distinction deliberately: the Distil checker tells you when we have explicitly assessed a pair and when we have not, because both are useful information. If you take Mesalazine (Systemic) alongside a supplement, the checker below will surface anything already in our database, and the missing-item form at the bottom of the page routes uncatalogued pairs into our next curation pass.
What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.
How we grade severity, choose what's in scope, and what we exclude.
Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.
Read the full methodologyWant this checked across everything you take?
This page checks the pairs you enter. The personalised Distil report goes further:
- the same graded, cited interaction check across your whole stack, not just the pairs you thought to type in
- where your current routine may be leaving you short of your goals
- the evidence-backed compounds worth adding, and the ones worth dropping
It's a paid report: £79, or £49 for the first 25 customers. The interactions check is one section of it, and you can read a real one in full before you buy.
See a real sample reportSomething missing?
If a supplement or medication you take isn't in our autocomplete, tell us. We go through what people flag every week and add what's missing.